Global In Vitro Diagnostics (IVD) Industry Outlook to 2024 - Strategic Recommendations are to Focus on Theranostics, Invest in Microbiology System Automation, Reduce the Cost of Diagnostic Tests
DUBLIN, Jan. 8, 2020 /PRNewswire/ -- The "Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The Global In Vitro Diagnostics Market was valued at USD 61,700.22 Million in the year 2018.
As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically.
Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.
Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained.
By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.
Scope of the Report
Global In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
-- In Vitro Diagnostics Market - Size, Growth, Forecast
-- Analysis By Technology: Centralised and Point of care, Diabetes Care,
Molecular Diagnostics, Tissue Diagnostics
-- Analysis By Application: Infectious Disease, Non Infectious Disease
-- Analysis By End-user: Hospital, Laboratory, Home Test, Others
-- Analysis By Product - Medical Devices, Reagents & Kits, Services
Regional Analysis - North America, Latin America, Asia Pacific, EMEA (Actual Period: 2014-2018, Forecast Period: 2019-2024)
-- In Vitro Diagnostics Market - Size, Growth, Forecast
-- Analysis By Technology: Centralised and Point of care, Diabetes Care,
Molecular Diagnostics, Tissue Diagnostics
-- Analysis By Application: Infectious Disease, Non Infectious Disease
-- Analysis By End-user: Hospital, Laboratory, Home Test, Others
-- Analysis By Product - Medical Devices, Reagents & Kits, Services
Country Analysis - USA, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)
-- In Vitro Diagnostics Market - Size, Growth, Forecast
-- Analysis By Technology: Centralised and Point of care, Diabetes Care,
Molecular Diagnostics, Tissue Diagnostics
-- Analysis By Application: Infectious Disease, Non Infectious Disease
-- Analysis By End-user: Hospital, Laboratory, Home Test, Others
-- Analysis By Product - Medical Devices, Reagents & Kits, Services
Other Report Highlights
-- Competitive Landscape
-- Leading Companies
-- Key Developments
-- Market Dynamics - Drivers & Restraints
-- Market Trends
-- SWOT Analysis
Companies Profiled
-- Abbott
-- Becton-Dickinson
-- Bio-Rad
-- bioMerieux
-- Danaher
-- Ortho Clinical Diagnostics
-- Roche
-- Siemens Healthineers
-- Sysmex
-- Thermofisher Scientific
Strategic Recommendations
-- Focus on Theranostics
-- Investment in Microbiology System Automation
-- Reducing the Cost of Diagnostic Test
For more information about this report visit https://www.researchandmarkets.com/r/jbtst3
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
